glp-1 receptor agonists effectiveness comparison Mapping the and risks of Comparative efficacy of glucagon-like peptide
Description
In more refractory cases, drugs with varied mechanisms of action (MOA) in combination are used in clinical practice (31)
A novel anti-inflammatory mechanism
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)
A commentary on association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target mendelian randomization and clinical trials. Int J Surg
Elsevier Inc
Feature Importance for ITE Estimation We applied SHAP values to identify the most influential features contributing to ITE variation
